MLYS
Price
$10.00
Change
-$0.26 (-2.53%)
Updated
Jan 24, 04:09 PM (EDT)
Capitalization
510.63M
47 days until earnings call
PLRX
Price
$10.93
Change
-$0.21 (-1.89%)
Updated
Jan 24, 04:13 PM (EDT)
Capitalization
677.91M
39 days until earnings call
Ad is loading...

MLYS vs PLRX

Header iconMLYS vs PLRX Comparison
Open Charts MLYS vs PLRXBanner chart's image
Mineralys Therapeutics
Price$10.00
Change-$0.26 (-2.53%)
Volume$200
Capitalization510.63M
Pliant Therapeutics
Price$10.93
Change-$0.21 (-1.89%)
Volume$2.01K
Capitalization677.91M
MLYS vs PLRX Comparison Chart
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. PLRX commentary
Jan 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and PLRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 25, 2025
Stock price -- (MLYS: $10.26 vs. PLRX: $11.14)
Brand notoriety: MLYS and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 95% vs. PLRX: 145%
Market capitalization -- MLYS: $510.63M vs. PLRX: $677.91M
MLYS [@Biotechnology] is valued at $510.63M. PLRX’s [@Biotechnology] market capitalization is $677.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 2 TA indicator(s) are bullish while PLRX’s TA Score has 2 bullish TA indicator(s).

  • MLYS’s TA Score: 2 bullish, 6 bearish.
  • PLRX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than MLYS.

Price Growth

MLYS (@Biotechnology) experienced а +8.00% price change this week, while PLRX (@Biotechnology) price change was -3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.81%. For the same industry, the average monthly price growth was +3.47%, and the average quarterly price growth was -1.20%.

Reported Earning Dates

MLYS is expected to report earnings on Mar 12, 2025.

PLRX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($678M) has a higher market cap than MLYS($511M). PLRX YTD gains are higher at: -15.414 vs. MLYS (-16.653). MLYS has higher annual earnings (EBITDA): -168.35M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. MLYS (264M). MLYS (0) and PLRX (0) have equivalent revenues.
MLYSPLRXMLYS / PLRX
Capitalization511M678M75%
EBITDA-168.35M-197.04M85%
Gain YTD-16.653-15.414108%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M405M65%
Total DebtN/A60.2M-
TECHNICAL ANALYSIS
Technical Analysis
MLYSPLRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 17 days ago
90%
Bullish Trend 17 days ago
88%
Momentum
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 17 days ago
90%
MACD
ODDS (%)
Bearish Trend 17 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 17 days ago
83%
Bearish Trend 17 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 17 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
89%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 26 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 17 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 17 days ago
86%
View a ticker or compare two or three
Ad is loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMINX65.670.47
+0.72%
Amana Income Institutional
JVAPX38.010.22
+0.58%
JPMorgan Value Advantage R3
CAPCX8.870.02
+0.23%
Federated Hermes Capital Income C
FRMCX25.420.02
+0.08%
Franklin Mutual Small-Mid Cap Val A
SDFSX18.02-0.04
-0.22%
Sit Small Cap Dividend Growth S

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PLRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+0.69%
PLRX - MLYS
44%
Loosely correlated
+2.01%
RCKT - MLYS
42%
Loosely correlated
+5.73%
ABOS - MLYS
42%
Loosely correlated
-1.14%
PRME - MLYS
42%
Loosely correlated
+2.52%
RXRX - MLYS
41%
Loosely correlated
+0.53%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+2.01%
RCKT - PLRX
51%
Loosely correlated
+5.73%
CRSP - PLRX
50%
Loosely correlated
+0.07%
NTLA - PLRX
50%
Loosely correlated
+2.54%
PRME - PLRX
50%
Loosely correlated
+2.52%
TRDA - PLRX
49%
Loosely correlated
+3.03%
More